Allergen immunotherapy found to pose no risk of infection

Investigators have found no evidence of infections related to the common practice of injecting allergens beneath the skin to reduce the allergic response. Although the sterility of these ‘allergy shots’ has not been a concern, the organization that sets standards for the quality and safety of medications has proposed revised guidelines that place them in the same category as preparations intended for intravenous or spinal administration.